Allianz Asset Management GmbH Acquires Shares of 22,451 Esperion Therapeutics Inc

Allianz Asset Management GmbH Acquires Shares of 22,451 Esperion Therapeutics Inc

Allianz Asset Management GmbH acquired a new stake in shares of Esperion Therapeutics Inc during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 22,451 shares of the biopharmaceutical company's stock, valued at approximately $1,624,000.

from Biotech News